FDA Says 'rapidly Works Toward' Emergency Use Approval Of J&J's Single-shot COVID-19 Vaccine

The U.S. Food and Drug Administration said that it will rapidly work toward finalization and issuance of an emergency use authorization of Johnson & Johnson's (JNJ) single-shot COVID-19 vaccine candidate.

The FDA's statement comes after positive advisory committee meeting outcome regarding the COVID-19 vaccine.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com